| [1] |
Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants[J]. Neurol Clin, 2013, 31(2): 491-510.doi:10.1016/j.ncl.2013.01.005.
pmid: 23642721
|
| [2] |
Bellanti R, Rinaldi S. Guillain-Barré syndrome: A comprehensive review[J]. Eur J Neurol, 2024, 31(8): e16365.doi:10.1111/ene.16365.
|
| [3] |
中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组. 中国吉兰-巴雷综合征诊治指南2024[J]. 中华神经科杂志, 2024, 57(9):936-944.doi:10.3760/cma.j.cn113694-20240220-00099.
|
| [4] |
Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy[J]. BMJ, 2019: 365: l1108.doi:10.1136/bmj.l1108.
|
| [5] |
姜霁纹, 冯立群, 张淑平, 等. 高同型半胱氨酸血症患者的周围神经损害及治疗观察[J]. 中国医药, 2014, 9(5): 661-665.doi:10.3760/cma.j.issn.16734777.2014.05.014.
|
| [6] |
Vijayan M, Chinniah R, Ravi PM, et al. MTHFR (C677T) CT genotype and CT-apoE3/3 genotypic combination predisposes the risk of ischemic stroke[J]. Gene, 2016, 591(2): 465-470.doi:10.1016/j.gene.2016.06.062.
pmid: 27378745
|
| [7] |
薛启蓂. 代谢、营养和中毒性周围神经病[J]. 中国临床神经科学, 2009, 17(1): 58-71.doi:10.3969/j.issn.1008-0678.2009.01.013.
|
| [8] |
Baltrusch S. The role of neurotropic B vitamins in nerve regeneration[J]. Biomed Res Int, 2021, 2021: 9968228.doi:10.1155/2021/9968228.
|
| [9] |
Kofahi R, Aldabbour B, Aljezawi M. A rare case with new insights: Pure sensory guillain barre syndrome with axonal features[J]. Int Med Case Rep J, 2020, 13: 543-549.doi:10.2147/IMCRJ.S280255.
|
| [10] |
Oh SJ, LaGanke C, Claussen GC. Sensory Guillain-Barré syndrome[J]. Neurology, 2001, 56(1): 82-86.doi:10.1212/wnl.56.1.82.
pmid: 11148240
|
| [11] |
Troen AM, Shea-Budgell M, Shukitt-Hale B, et al. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice[J]. Proc Natl Acad Sci U S A, 2008, 105(34): 12474-12479.doi:10.1073/pnas.0805350105.
|
| [12] |
Obeid R, McCaddon A, Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases[J]. Clin Chem Lab Med, 2007, 45(12): 1590-1606.doi:10.1515/CCLM.2007.356.
pmid: 18067446
|
| [13] |
Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps[J]. Nat Rev Neurol, 2019, 15(11): 671-683.doi:10.1038/s41582-019-0250-9.
pmid: 31541214
|
| [14] |
Packiyarajah P, Sundaresan KT, Nusair MSM. Rare sensory ataxic variant of Guillain-Barre syndrome: A case report[J]. Cureus, 2023, 15(6): e40920.doi:10.7759/cureus.40920.
|
| [15] |
黄刚, 李灵娟, 谢旭芳, 等. 感觉型吉兰巴雷综合征1例报道及文献回顾性总结分析[J]. 重庆医学, 2017, 46(2): 254-255.doi:10.3969/j.issn.1671-8348.2017.02.037.
|
| [16] |
Terkelsen AJ, Karlsson P, Lauria G, et al. The diagnostic challenge of small fibre neuropathy: Clinical presentations, evaluations, and causes[J]. Lancet Neurol, 2017, 16(11): 934-944.doi:10.1016/S1474-4422(17)30329-0.
pmid: 29029847
|
| [17] |
Schessl J, Koga M, Funakoshi K, et al. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome[J]. Arch Dis Child, 2007, 92(1): 48-52.doi:10.1136/adc.2006.098061.
pmid: 16920757
|
| [18] |
Zhu W, Li K, Cui T, et al. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome[J]. Ann Transl Med, 2023, 11(7): 289.doi:10.21037/atm-20-2285.
|
| [19] |
Kusunoki S, Kaida K. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders[J]. J Neurochem, 2011, 116(5): 828-832.doi:10.1111/j.1471-4159.2010.07029.x.
|
| [20] |
van den Berg LH, Lankamp CL, de Jager AE, et al. Anti-sulphatide antibodies in peripheral neuropathy[J]. J Neurol Neurosurg Psychiatry, 1993, 56(11): 1164-1168.doi:10.1136/jnnp.56.11.1164.
|
| [21] |
Zhang J, Gan J, Wang J. Anti-sulfatide antibody associated GBS with headache and abdominal pain: A case report[J]. BMC Pediatrics, 2024, 24: 414.doi:10.1186/s12887-023-04287-5.
pmid: 38926645
|
| [22] |
章娟娟, 周农, 汪凯, 等. 双重抗神经节苷脂抗体阳性患者临床特征分析[J]. 安徽医学, 2021, 42(6): 591-594.doi:10.3969/j.issn.1000-0399.2021.06.001.
|
| [23] |
Semproni M, Gibson G, Kuyper L, et al. Unusual sensory variant of Guillain-Barré syndrome[J]. BMJ Case Reports, 2017, 2017: bcr2016218935, bcr-2016-218935.doi:10.1136/bcr-2016-218935.
|